panitumumab,Fluorouracil,Leucovorin,Oxaliplatin
Amgen,Takeda
['fluoro', 'colorectal', 'irinotecan', 'triplet', 'triplete', 'panitumumab', 'rectal']
upfront modified fluorouracil, leucovorin, oxaliplatin, and irinotecan plus panitumumab versus fluorouracil, leucovorin, and oxaliplatin plus panitumumab for patients with ras/braf wild-type metastatic colorectal cancer: phase iii triplete study #asco22 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis